Pharsight

Implanon patents expiration

IMPLANON's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9757552 ORGANON Applicator for inserting an implant
Jul, 2030

(6 years from now)

Implanon is owned by Organon.

Implanon contains Etonogestrel.

Implanon has a total of 1 drug patent out of which 0 drug patents have expired.

Implanon was authorised for market use on 17 July, 2006.

Implanon is available in implant;implantation dosage forms.

Implanon can be used as prevention of pregnancy.

The generics of Implanon are possible to be released after 28 July, 2030.

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) May 31, 2014

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using ETONOGESTREL ingredient

Market Authorisation Date: 17 July, 2006

Treatment: Prevention of pregnancy

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage

IMPLANON family patents

Family Patents